Skip to main content

Clarient, Inc. Investors File Lawsuit Against Directors

  • If you are a current investor in Clarient, Inc. (NASDAQ:CLRT) common or preferred shares, you have certain options and should you contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

A Clarient investor filed a lawsuit in State Court alleging breaches of fiduciary duty arising out of the attempt to sell Clarient too cheaply to GE Healthcare. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties owed to Clarient, Inc. (NASDAQ:CLRT) investors for trying to sell Clarient through a “grossly inadequate” offer. On Friday,...



You must register (for free) or login to view the entire case.